Julia C Dombrowski1, Susan E Buskin, Amy Bennett, Hanne Thiede, Matthew R Golden. 1. *Department of Medicine, University of Washington, Seattle, WA; †Public Health-Seattle and King County HIV/STD Program, Seattle, WA; and ‡Department of Epidemiology, University of Washington, Seattle, WA.
Abstract
OBJECTIVES: To assess the HIV care continuum among HIV-infected persons residing in Seattle and King County, WA, at the end of 2011 and compare estimates of viral suppression derived from different population-based data sources. METHODS: We derived estimates for the HIV care continuum using a combination of HIV case and laboratory surveillance data supplemented with individual investigation of cases that seemed to be unlinked to or not retained in HIV care, a jurisdiction-wide population-based retrospective chart review, and local data from the CDC's Medical Monitoring Project and National HIV Behavioral Surveillance. RESULTS: Adjusting for in- and out-migration of persons diagnosed with HIV, laboratory surveillance data supplemented with individual case investigation suggest that 67% of persons diagnosed with HIV and 57% of all HIV-infected persons living in King County at the end of 2011 were virally suppressed (plasma HIV RNA <200 copies/mL). The viral suppression estimates we derived from a population-based chart review and adjusted local Medical Monitoring Project data were similar to the surveillance-derived estimate and identical to each other (59% viral suppression among all HIV-infected persons). CONCLUSIONS: The level of viral suppression in King County is more than twice the national estimate and exceeds estimates of control for other major chronic diseases in the United States. Our findings suggest that national care continuum estimates may be substantially too pessimistic and highlight the need to improve HIV surveillance data.
OBJECTIVES: To assess the HIV care continuum among HIV-infectedpersons residing in Seattle and King County, WA, at the end of 2011 and compare estimates of viral suppression derived from different population-based data sources. METHODS: We derived estimates for the HIV care continuum using a combination of HIV case and laboratory surveillance data supplemented with individual investigation of cases that seemed to be unlinked to or not retained in HIV care, a jurisdiction-wide population-based retrospective chart review, and local data from the CDC's Medical Monitoring Project and National HIV Behavioral Surveillance. RESULTS: Adjusting for in- and out-migration of persons diagnosed with HIV, laboratory surveillance data supplemented with individual case investigation suggest that 67% of persons diagnosed with HIV and 57% of all HIV-infectedpersons living in King County at the end of 2011 were virally suppressed (plasma HIV RNA <200 copies/mL). The viral suppression estimates we derived from a population-based chart review and adjusted local Medical Monitoring Project data were similar to the surveillance-derived estimate and identical to each other (59% viral suppression among all HIV-infectedpersons). CONCLUSIONS: The level of viral suppression in King County is more than twice the national estimate and exceeds estimates of control for other major chronic diseases in the United States. Our findings suggest that national care continuum estimates may be substantially too pessimistic and highlight the need to improve HIV surveillance data.
Authors: Gary Marks; Lytt I Gardner; Jason Craw; Thomas P Giordano; Michael J Mugavero; Jeanne C Keruly; Tracey E Wilson; Lisa R Metsch; Mari-Lynn Drainoni; Faye Malitz Journal: Clin Infect Dis Date: 2011-10-05 Impact factor: 9.079
Authors: Edward M Gardner; Margaret P McLees; John F Steiner; Carlos Del Rio; William J Burman Journal: Clin Infect Dis Date: 2011-03-15 Impact factor: 9.079
Authors: Bohdan Nosyk; Julio S G Montaner; Guillaume Colley; Viviane D Lima; Keith Chan; Katherine Heath; Benita Yip; Hasina Samji; Mark Gilbert; Rolando Barrios; Réka Gustafson; Robert S Hogg Journal: Lancet Infect Dis Date: 2013-09-27 Impact factor: 25.071
Authors: Jeanne Bertolli; R Luke Shouse; Linda Beer; Eduardo Valverde; Jennifer Fagan; Samuel M Jenness; Afework Wogayehu; Christopher Johnson; Alan Neaigus; Daniel Hillman; Maria Courogen; Kathleen A Brady; Barbara Bolden Journal: Open AIDS J Date: 2012-09-07
Authors: Joanna M Bove; Matthew R Golden; Shireesha Dhanireddy; Robert D Harrington; Julia C Dombrowski Journal: J Acquir Immune Defic Syndr Date: 2015-11-01 Impact factor: 3.731
Authors: Julia C Dombrowski; Joanna Bove; James C Roscoe; Jessica Harvill; Caislin L Firth; Shireen Khormooji; Jason Carr; Peter Choi; Courtney Smith; Sean D Schafer; Matthew R Golden Journal: J Acquir Immune Defic Syndr Date: 2017-02-01 Impact factor: 3.731
Authors: McKaylee M Robertson; Sarah L Braunstein; Donald R Hoover; Sheng Li; Denis Nash Journal: Clin Infect Dis Date: 2020-11-05 Impact factor: 9.079
Authors: Katerina A Christopoulos; Susan Scheer; Wayne T Steward; Revery Barnes; Wendy Hartogensis; Edwin D Charlebois; Stephen F Morin; Hong-Ha M Truong; Elvin H Geng Journal: J Acquir Immune Defic Syndr Date: 2015-05-01 Impact factor: 3.731
Authors: Katelynne Gardner Toren; Susan E Buskin; Julia C Dombrowski; Susan L Cassels; Matthew R Golden Journal: Sex Transm Dis Date: 2016-01 Impact factor: 2.830
Authors: Eva A Enns; Cavan S Reilly; Beth A Virnig; Karen Baker; Nicholas Vogenthaler; Keith Henry Journal: AIDS Patient Care STDS Date: 2016-09 Impact factor: 5.078